These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

218 related items for PubMed ID: 29284076

  • 1. Percutaneous hepatic perfusion with melphalan in uveal melanoma: A safe and effective treatment modality in an orphan disease.
    Karydis I, Gangi A, Wheater MJ, Choi J, Wilson I, Thomas K, Pearce N, Takhar A, Gupta S, Hardman D, Sileno S, Stedman B, Zager JS, Ottensmeier C.
    J Surg Oncol; 2018 May; 117(6):1170-1178. PubMed ID: 29284076
    [Abstract] [Full Text] [Related]

  • 2. Percutaneous isolated hepatic perfusion (chemosaturation) with melphalan following right hemihepatectomy in patients with cholangiocarcinoma and metastatic uveal melanoma: peri- and post-interventional adverse events and therapy response compared to a matched group without prior liver surgery.
    Dewald CLA, Becker LS, Maschke SK, Meine TC, Alten TA, Kirstein MM, Vogel A, Wacker FK, Meyer BC, Hinrichs JB.
    Clin Exp Metastasis; 2020 Dec; 37(6):683-692. PubMed ID: 33034815
    [Abstract] [Full Text] [Related]

  • 3. Chemosaturation with percutaneous hepatic perfusion of melphalan for liver-dominant metastatic uveal melanoma: a single center experience.
    Artzner C, Mossakowski O, Hefferman G, Grosse U, Hoffmann R, Forschner A, Eigentler T, Syha R, Grözinger G.
    Cancer Imaging; 2019 May 30; 19(1):31. PubMed ID: 31146793
    [Abstract] [Full Text] [Related]

  • 4. Chemosaturation with Percutaneous Hepatic Perfusion: Outcome and Safety in Patients with Metastasized Uveal Melanoma.
    Dewald CLA, Hinrichs JB, Becker LS, Maschke S, Meine TC, Saborowski A, Schönfeld LJ, Vogel A, Kirstein MM, Wacker FK.
    Rofo; 2021 Aug 30; 193(8):928-936. PubMed ID: 33535258
    [Abstract] [Full Text] [Related]

  • 5. Chemosaturation with percutaneous hepatic perfusion of melphalan for metastatic uveal melanoma.
    Modi S, Gibson T, Vigneswaran G, Patel S, Wheater M, Karydis I, Gupta S, Takhar A, Pearce N, Ottensmeier C, Stedman B.
    Melanoma Res; 2022 Apr 01; 32(2):103-111. PubMed ID: 35254333
    [Abstract] [Full Text] [Related]

  • 6. Chemosaturation with percutaneous hepatic perfusion is effective in patients with ocular melanoma and cholangiocarcinoma.
    Schönfeld L, Hinrichs JB, Marquardt S, Voigtländer T, Dewald C, Koppert W, Manns MP, Wacker F, Vogel A, Kirstein MM.
    J Cancer Res Clin Oncol; 2020 Nov 01; 146(11):3003-3012. PubMed ID: 32564137
    [Abstract] [Full Text] [Related]

  • 7. Over 12 Years Single Institutional Experience Performing Percutaneous Hepatic Perfusion for Unresectable Liver Metastases.
    Carr MJ, Sun J, Cohen JB, Liu J, Serdiuk AA, Stewart SR, Doobay N, Duclos A, Seal DA, Choi J, Zager JS.
    Cancer Control; 2020 Nov 01; 27(1):1073274820983019. PubMed ID: 33372814
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Quality of Life Analysis of Patients Treated with Percutaneous Hepatic Perfusion for Uveal Melanoma Liver Metastases.
    Tong TML, Fiocco M, van Duijn-de Vreugd JJ, Lutjeboer J, Speetjens FM, Tijl FGJ, Sitsen ME, Zoethout RWM, Martini CH, Vahrmeijer AL, van der Meer RW, van Rijswijk CSP, van Erkel AR, Kapiteijn E, Burgmans MC.
    Cardiovasc Intervent Radiol; 2024 Jun 01; 47(6):741-750. PubMed ID: 38587534
    [Abstract] [Full Text] [Related]

  • 15. Efficacy and Safety of the Melphalan/Hepatic Delivery System in Patients with Unresectable Metastatic Uveal Melanoma: Results from an Open-Label, Single-Arm, Multicenter Phase 3 Study.
    Zager JS, Orloff M, Ferrucci PF, Choi J, Eschelman DJ, Glazer ES, Ejaz A, Howard JH, Richtig E, Ochsenreither S, Reddy SA, Lowe MC, Beasley GM, Gesierich A, Bender A, Gschnell M, Dummer R, Rivoire M, Arance A, Fenwick SW, Sacco JJ, Haferkamp S, Weishaupt C, John J, Wheater M, Ottensmeier CH.
    Ann Surg Oncol; 2024 Aug 01; 31(8):5340-5351. PubMed ID: 38704501
    [Abstract] [Full Text] [Related]

  • 16. Optimizing the treatment of liver metastases from uveal melanomas with transarterial chemoembolization using melphalan and calibrated microspheres.
    Carle X, Gastaud L, Salleron J, Tardy MP, Caujolle JP, Thyss A, Thariat J, Chevallier P.
    Bull Cancer; 2020 Dec 01; 107(12):1274-1283. PubMed ID: 33183739
    [Abstract] [Full Text] [Related]

  • 17. Safety and efficacy of chemosaturation in patients with primary and secondary liver tumors.
    Kirstein MM, Marquardt S, Jedicke N, Marhenke S, Koppert W, Manns MP, Wacker F, Vogel A.
    J Cancer Res Clin Oncol; 2017 Oct 01; 143(10):2113-2121. PubMed ID: 28634727
    [Abstract] [Full Text] [Related]

  • 18. Isolated hepatic perfusion as a treatment for liver metastases of uveal melanoma.
    Ben-Shabat I, Hansson C, Sternby Eilard M, Cahlin C, Rizell M, Lindnér P, Mattsson J, Olofsson Bagge R.
    J Vis Exp; 2015 Jan 25; (95):52490. PubMed ID: 25650893
    [Abstract] [Full Text] [Related]

  • 19. Results of a Randomized Controlled Multicenter Phase III Trial of Percutaneous Hepatic Perfusion Compared with Best Available Care for Patients with Melanoma Liver Metastases.
    Hughes MS, Zager J, Faries M, Alexander HR, Royal RE, Wood B, Choi J, McCluskey K, Whitman E, Agarwala S, Siskin G, Nutting C, Toomey MA, Webb C, Beresnev T, Pingpank JF.
    Ann Surg Oncol; 2016 Apr 25; 23(4):1309-19. PubMed ID: 26597368
    [Abstract] [Full Text] [Related]

  • 20. Repeated percutaneous hepatic perfusion with melphalan can maintain long-term response in patients with liver cancers.
    Veelken R, Maiwald B, Strocka S, Petersen TO, Moche M, Ebel S, Denecke T, Rehak M, Struck MF, Forstmeyer D, Rademacher S, Seehofer D, Berg T, van Bömmel F.
    Cardiovasc Intervent Radiol; 2022 Feb 25; 45(2):218-222. PubMed ID: 34716470
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.